Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven J Ackerman

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
The Journal of Biological Chemistry|February 9, 2002
Charcot-Leyden crystal protein (galectin-10) is not a dual function galectin with lysophospholipase activity but binds a lysophospholipase inhibitor in a novel structural fashionSteven J Ackerman, Li Liu, Mark A Kwatia, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|July 23, 2020
Neonatal therapy with PF543, a sphingosine kinase 1 inhibitor, ameliorates hyperoxia-induced airway remodeling in a murine model of bronchopulmonary dysplasiaAlison W Ha, Tara Sudhadevi, David L Ebenezer, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 18, 2005
Eosinophils alter colonic epithelial barrier function: role for major basic proteinGlenn T Furuta, Edward E S Nieuwenhuis, Jorn Karhausen, et al.
The Journal of Biological Chemistry|February 16, 2006
Systematic evaluation of transcellular activities of secretory phospholipases A2. High activity of group V phospholipases A2 to induce eicosanoid biosynthesis in neighboring inflammatory cellsGihani T Wijewickrama, Jin-Hahn Kim, Young Jun Kim, et al.
The Journal of Allergy and Clinical Immunology|January 27, 2020
Charcot-Leyden crystal protein/galectin-10 interacts with cationic ribonucleases and is required for eosinophil granulogenesisMilica M Grozdanovic, Christine B Doyle, Li Liu, et al.
Journal of Clinical Immunology|September 23, 2011
Developmental, malignancy-related, and cross-species analysis of eosinophil, mast cell, and basophil siglec-8 expressionSherry A Hudson, Harald Herrmann, Jian Du, et al.
Allergy|August 7, 2019
Colony-stimulating factor 1 and its receptor are new potential therapeutic targets for allergic asthmaHyung-Geun Moon, Seung-Jae Kim, Myoung Kyu Lee, et al.
The Journal of Allergy and Clinical Immunology|April 11, 2022
Esophageal remodeling in eosinophilic esophagitis: Relationships to luminal captured biomarkers of inflammation and periostinAmanda B Muir, Steven J Ackerman, Zhaoxing Pan, et al.
Blood|January 9, 2015
Acetylation of C/EBPε is a prerequisite for terminal neutrophil differentiationMarije Bartels, Anita M Govers, Veerle Fleskens, et al.
The Journal of Allergy and Clinical Immunology|May 21, 2018
Novel peptide nanoparticle-biased antagonist of CCR3 blocks eosinophil recruitment and airway hyperresponsivenessMilica Grozdanovic, Kimberly G Laffey, Hazem Abdelkarim, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
The Journal of Biological Chemistry|February 9, 2002
Charcot-Leyden crystal protein (galectin-10) is not a dual function galectin with lysophospholipase activity but binds a lysophospholipase inhibitor in a novel structural fashionSteven J Ackerman, Li Liu, Mark A Kwatia, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|July 23, 2020
Neonatal therapy with PF543, a sphingosine kinase 1 inhibitor, ameliorates hyperoxia-induced airway remodeling in a murine model of bronchopulmonary dysplasiaAlison W Ha, Tara Sudhadevi, David L Ebenezer, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 18, 2005
Eosinophils alter colonic epithelial barrier function: role for major basic proteinGlenn T Furuta, Edward E S Nieuwenhuis, Jorn Karhausen, et al.
The Journal of Biological Chemistry|February 16, 2006
Systematic evaluation of transcellular activities of secretory phospholipases A2. High activity of group V phospholipases A2 to induce eicosanoid biosynthesis in neighboring inflammatory cellsGihani T Wijewickrama, Jin-Hahn Kim, Young Jun Kim, et al.
The Journal of Allergy and Clinical Immunology|January 27, 2020
Charcot-Leyden crystal protein/galectin-10 interacts with cationic ribonucleases and is required for eosinophil granulogenesisMilica M Grozdanovic, Christine B Doyle, Li Liu, et al.
Journal of Clinical Immunology|September 23, 2011
Developmental, malignancy-related, and cross-species analysis of eosinophil, mast cell, and basophil siglec-8 expressionSherry A Hudson, Harald Herrmann, Jian Du, et al.
Allergy|August 7, 2019
Colony-stimulating factor 1 and its receptor are new potential therapeutic targets for allergic asthmaHyung-Geun Moon, Seung-Jae Kim, Myoung Kyu Lee, et al.
The Journal of Allergy and Clinical Immunology|April 11, 2022
Esophageal remodeling in eosinophilic esophagitis: Relationships to luminal captured biomarkers of inflammation and periostinAmanda B Muir, Steven J Ackerman, Zhaoxing Pan, et al.
Blood|January 9, 2015
Acetylation of C/EBPε is a prerequisite for terminal neutrophil differentiationMarije Bartels, Anita M Govers, Veerle Fleskens, et al.
The Journal of Allergy and Clinical Immunology|May 21, 2018
Novel peptide nanoparticle-biased antagonist of CCR3 blocks eosinophil recruitment and airway hyperresponsivenessMilica Grozdanovic, Kimberly G Laffey, Hazem Abdelkarim, et al.
Pageof 7